Tristel (TSTL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 437.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 465.00
  • 52 Week Low: 295.00
  • Currency: UK Pounds
  • Shares Issued: 47.40m
  • Volume: 18,391
  • Market Cap: £207.38m
  • RiskGrade: 180

Tristel Overview

We are an infection prevention company. The entire purpose of our business is to prevent the transmission of microbes from one object or person to another. We achieve our mission by applying a very powerful biocidal chemistry – chlorine dioxide – to the target environmental surface or medical device. We are one of a very few companies worldwide that can legitimately claim to be exclusively an infection prevention business.
Competitors: Trellus Health, Open Orphan , Mediclinic International , Cambridge Cognition Holdings, Sourcebio International, Sensyne Health, CareTech Holding, Diaceutics

Key Personnel

CEO: Paul Christopher Swinney
Executive Director: Bart Leemans
Finance Director: Elizabeth Dixon
Independent Non-Executive Director: Isabel J S Napper
Independent Non-Executive Director: Caroline Stephens
Non-Executive Chairman: Bruno Holthof
Senior Independent Non-Executive Director: Tom Jenkins
Non-Executive Dir: David Orr

Contact Details

Address: Unit 1B Lynx Business Park, Fordham Road, Snailwell, Newmarket, Cambridgeshire , United Kingdom, CB8 7NY
Phone: 44 (0) 1638 721500
Fax: 44 (0) 1638 721911
Website: http://www.tristel.com

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share
ISIN: GB00B07RVT99

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Tristel Market Data

Currency UK Pounds
Share Price 437.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 465.00
52 Week Low 295.00
Volume 18,391
Shares Issued 47.40m
Market Cap £207.38m
RiskGrade 180

Tristel Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.7% below the market average98.7% below the market average98.7% below the market average98.7% below the market average98.7% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
68.03% above the market average68.03% above the market average68.03% above the market average68.03% above the market average68.03% above the market average
72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average
Income
90.48% below the market average90.48% below the market average90.48% below the market average90.48% below the market average90.48% below the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
2.74% above the market average2.74% above the market average2.74% above the market average2.74% above the market average2.74% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Tristel Dividends

  Latest Previous
  Final Interim
Ex-Div 23-Nov-23 16-Mar-23
Paid 22-Dec-23 11-Apr-23
Amount 7.88p 2.62p

Trades for 08-Dec-2023

Time Volume / Share Price
14:55 12,000 @ 444.00p
15:41 100 @ 440.00p
15:39 1,138 @ 438.25p
15:13 41 @ 438.25p
14:22 2,500 @ 438.44p

Tristel Key Personnel

CEO Paul Christopher Swinney
Finance Director Elizabeth Dixon

Top of Page